191 participants
Study of the Efficacy and Safety of Immune Globulin Intravenous (Human) Flebogamma® 5% Dual Inactivation and Filtration (DIF) in Participants With Post-polio Syndrome
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2025-12-05
- Start Date:
- 2014-09-23
- Completion:
- 2022-11-24
Conditions
- Post-polio Syndrome
Interventions
- BIOLOGICAL
- DRUG